Advances in peptide-based drug delivery systems

Drug delivery systems (DDSs) are designed to deliver drugs to their specific targets to minimize their toxic effects and improve their susceptibility to clearance during targeted transport. Peptides have high affinity, low immunogenicity, simple amino acid composition, and adjustable molecular size;...

Full description

Bibliographic Details
Main Authors: Sijie Guo, Jing Wang, Qi Wang, Jinxin Wang, Song Qin, Wenjun Li
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024020401
_version_ 1797267773825482752
author Sijie Guo
Jing Wang
Qi Wang
Jinxin Wang
Song Qin
Wenjun Li
author_facet Sijie Guo
Jing Wang
Qi Wang
Jinxin Wang
Song Qin
Wenjun Li
author_sort Sijie Guo
collection DOAJ
description Drug delivery systems (DDSs) are designed to deliver drugs to their specific targets to minimize their toxic effects and improve their susceptibility to clearance during targeted transport. Peptides have high affinity, low immunogenicity, simple amino acid composition, and adjustable molecular size; therefore, most peptides can be coupled to drugs via linkers to form peptide-drug conjugates (PDCs) and act as active pro-drugs. PDCs are widely thought to be promising DDSs, given their ability to improve drug bio-compatibility and physiological stability. Peptide-based DDSs are often used to deliver therapeutic substances such as anti-cancer drugs and nucleic acid-based drugs, which not only slow the degradation rate of drugs in vivo but also ensure the drug concentration at the targeted site and prolong the half-life of drugs in vivo. This article provides an profile of the advancements and future development in functional peptide-based DDSs both domestically and internationally in recent years, in the expectation of achieving targeted drug delivery incorporating functional peptides and taking full advantage of synergistic effects.
first_indexed 2024-04-25T01:21:55Z
format Article
id doaj.art-ebdc36a3bfac47bc9e3c51b52150a378
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-25T01:21:55Z
publishDate 2024-02-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-ebdc36a3bfac47bc9e3c51b52150a3782024-03-09T09:26:51ZengElsevierHeliyon2405-84402024-02-01104e26009Advances in peptide-based drug delivery systemsSijie Guo0Jing Wang1Qi Wang2Jinxin Wang3Song Qin4Wenjun Li5Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, Shandong, 266112, China; Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, Shandong, 264003, ChinaYantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, Shandong, 264003, ChinaQingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, Shandong, 266112, China; Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, Shandong, 264003, ChinaCollege of Life Sciences, Yantai University, Yantai, 264005, ChinaYantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, Shandong, 264003, ChinaQingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, Shandong, 266112, China; Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, Shandong, 264003, China; Corresponding author. Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, Shandong, 266112, China.Drug delivery systems (DDSs) are designed to deliver drugs to their specific targets to minimize their toxic effects and improve their susceptibility to clearance during targeted transport. Peptides have high affinity, low immunogenicity, simple amino acid composition, and adjustable molecular size; therefore, most peptides can be coupled to drugs via linkers to form peptide-drug conjugates (PDCs) and act as active pro-drugs. PDCs are widely thought to be promising DDSs, given their ability to improve drug bio-compatibility and physiological stability. Peptide-based DDSs are often used to deliver therapeutic substances such as anti-cancer drugs and nucleic acid-based drugs, which not only slow the degradation rate of drugs in vivo but also ensure the drug concentration at the targeted site and prolong the half-life of drugs in vivo. This article provides an profile of the advancements and future development in functional peptide-based DDSs both domestically and internationally in recent years, in the expectation of achieving targeted drug delivery incorporating functional peptides and taking full advantage of synergistic effects.http://www.sciencedirect.com/science/article/pii/S2405844024020401Functional peptideDrug delivery systemPeptide-drug couplingApplication prospects
spellingShingle Sijie Guo
Jing Wang
Qi Wang
Jinxin Wang
Song Qin
Wenjun Li
Advances in peptide-based drug delivery systems
Heliyon
Functional peptide
Drug delivery system
Peptide-drug coupling
Application prospects
title Advances in peptide-based drug delivery systems
title_full Advances in peptide-based drug delivery systems
title_fullStr Advances in peptide-based drug delivery systems
title_full_unstemmed Advances in peptide-based drug delivery systems
title_short Advances in peptide-based drug delivery systems
title_sort advances in peptide based drug delivery systems
topic Functional peptide
Drug delivery system
Peptide-drug coupling
Application prospects
url http://www.sciencedirect.com/science/article/pii/S2405844024020401
work_keys_str_mv AT sijieguo advancesinpeptidebaseddrugdeliverysystems
AT jingwang advancesinpeptidebaseddrugdeliverysystems
AT qiwang advancesinpeptidebaseddrugdeliverysystems
AT jinxinwang advancesinpeptidebaseddrugdeliverysystems
AT songqin advancesinpeptidebaseddrugdeliverysystems
AT wenjunli advancesinpeptidebaseddrugdeliverysystems